▲ Peaking
Health
Rare transplant gives Stage 4 lung cancer patients a second chance at life
A new study suggests lung transplants may significantly improve survival rates for patients with terminal, Stage 4 lung cancer.
Lung Cancer
2 trends tracked about this subject — the full history, oldest to newest below.
◼ Archived
Business
🔮 fades ✓
Pfizer Announces Topline Phase 3 Results for Sigvotatug Vedotin in Previously Treated Metastatic Non-Squamous Non-Small Cell Lung Cancer
Pfizer's Phase 3 trial for the lung cancer drug Sigvotatug Vedotin failed to meet its primary endpoint for survival.